Stay updated on Nivolumab in Advanced Squamous Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab in Advanced Squamous Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab in Advanced Squamous Lung Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    No significant changes were observed in the study details page for NCT01721759; the content remains focused on the completed trial's record.
    Difference
    0.3%
    Check dated 2025-10-28T05:32:51.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    Significant update: new operating-status notice and version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    3%
    Check dated 2025-10-06T16:00:47.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    - Updated version from v3.0.2 to v3.1.0. - No other content changes detected.
    Difference
    0.1%
    Check dated 2025-09-29T09:55:34.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.1 to v3.0.2; removed the 'Back to Top' element. No substantive changes to core content, pricing, stock, times, or names.
    Difference
    0.2%
    Check dated 2025-09-15T00:19:45.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T20:47:38.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new facility names and locations in France and Germany, as well as a range of new scientific terms related to antibodies and proteins. Notably, previous content related to lung cancer and various neoplasms has been removed.
    Difference
    4%
    Check dated 2025-08-31T13:17:45.000Z thumbnail image

Stay in the know with updates to Nivolumab in Advanced Squamous Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab in Advanced Squamous Lung Cancer Clinical Trial page.